A Trial Investigating the Safety and Effects of One or Two Additional Doses of Comirnaty or One Dose of BNT162b2s01 in BNT162-01 or BNT162-04 Trial Subjects

Clinical trial NCT04949490 · COMPLETED

Trial details

NCT number: NCT04949490
Sponsor: BioNTech SE
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 SARS-CoV-2 Infection

Start date: 2021-07-26
Primary completion: 2022-04-14
Enrollment: 137

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.